CNBC

Novo Nordisk’s Wegovy weight loss drug sales soar 67% in second quarter

6 8 月, 2025

One Min Read

8 Views

Novo Nordisk last week cut its full-year guidance and named Mike Doustdar as its new CEO.

原文: https://www.cnbc.com/2025/08/06/novo-nordisk-nvo-earnings-q2-2025.html

Last Update: 6 8 月, 2025

Written By

Other Articles

Previous

兰开夏控股强劲上半年业绩后上调股本回报率指引

Next

Honda Motor quarterly profit halves as U.S. auto tariffs bite

Related Posts

Retail investors are running head first into this topsy-turvy market

1 Min Read

Third Point, D.E. Shaw obtain agreements with CoStar. How the activists can build value

1 Min Read

Top Wall Street analysts find these 3 stocks attractive in these challenging times

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept